Skip to content

Randomized double-blind controlled study on the therapeutic effect of rhubarb powder on acute pancreatitis

Randomized double-blind controlled study on the therapeutic effect of rhubarb powder on acute pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052568
Enrollment
Unknown
Registered
2021-10-31
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

experimental group:Rhubarb
control group:Vitamin B2

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 75 years, male or female; 2. According to the Atlanta classification standard (Revised Version) issued by the International Association of pancreatic diseases in 2012, they meet the AP diagnosis: abdominal pain, blood amylase and lipase >= 3 times the upper limit of normal value, abdominal CT has pancreatic edema and other lesions.

Exclusion criteria

Exclusion criteria: AP with malignant tumor, pancreatic cancer, severe basic diseases: heart failure, liver disease, immune diseases, organ transplantation, hematological diseases, rhubarb allergy.

Design outcomes

Primary

MeasureTime frame
routine blood test;Blood biochemistry;Arterial blood gas index;Pancreatitis score;Abdominal CT;Abdominal bowel sounds;endotoxin;Intestinal flora translocation index;Fecal flora;

Countries

China

Contacts

Public ContactLi Chunsheng

Beijing Friendship Hospital, Capital Medical University

lcscyyy2@163.com+86 13681392380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026